Literature DB >> 19669105

[Haemodynamic monitoring in the perioperative phase. Available systems, practical application and clinical data].

U Wittkowski1, C Spies, M Sander, J Erb, A Feldheiser, C von Heymann.   

Abstract

A regular hydration status and compensated vascular filling are targets of perioperative fluid and volume management and, in parallel, represent precautions for sufficient stroke volume and cardiac output to maintain tissue oxygenation. The physiological and pathophysiological effects of fluid and volume replacement mainly depend on the pharmacological properties of the solutions used, the magnitude of the applied volume as well as the timing of volume replacement during surgery. In the perioperative setting surgical stress induces physiological and hormonal adaptations of the body, which in conjunction with an increased permeability of the vascular endothelial layer influence fluid and volume management. The target of haemodynamic monitoring in the operation room is to collect data on haemodynamics and global oxygen transport, which enable the anaesthetist to estimate the volume status of the vascular system. Particularly in high risk patients this may improve fluid and volume therapy with respect to maintaining cardiac output. A goal-directed volume management aiming at preventing hypovolaemia may improve the outcome after surgery. The objective of this article is to review the monitoring devices that are currently used to assess haemodynamics and filling status in the perioperative setting. Methods and principles for measuring haemodynamic variables, the measured and calculated parameters as well as clinical benefits and shortcomings of each device are described. Furthermore, the results for monitoring devices from clinical studies of goal-directed fluid and volume therapy which have been published will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669105     DOI: 10.1007/s00101-009-1590-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  104 in total

1.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

2.  Correlation of oxygen delivery with central venous oxygen saturation, mean arterial pressure and heart rate in piglets.

Authors:  Wilhelm A Osthaus; Dirk Huber; Carsten Beck; Anja Roehler; Gernot Marx; Hartmut Hecker; Robert Sümpelmann
Journal:  Paediatr Anaesth       Date:  2006-09       Impact factor: 2.556

3.  Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.

Authors:  S Nuñez; A Maisel
Journal:  Am Heart J       Date:  1998-03       Impact factor: 4.749

4.  The new pulmonary artery catheters: continuous venous oximetry, right ventricular ejection fraction, and continuous cardiac output.

Authors:  L D Nelson
Journal:  New Horiz       Date:  1997-08

Review 5.  The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 6.  [Mechanical ventilation-related variability of stroke volume. Clinical evaluation and therapeutic implications].

Authors:  F Michard; J L Teboul
Journal:  Rev Mal Respir       Date:  2001-12       Impact factor: 0.622

7.  Influence of tidal volume on left ventricular stroke volume variation measured by pulse contour analysis in mechanically ventilated patients.

Authors:  Daniel A Reuter; Julian Bayerlein; Matthias S G Goepfert; Florian C Weis; Erich Kilger; Peter Lamm; Alwin E Goetz
Journal:  Intensive Care Med       Date:  2003-02-11       Impact factor: 17.440

8.  Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.

Authors:  C Richard; C Thuillez; M Pezzano; G Bottineau; J F Giudicelli; P Auzepy
Journal:  Chest       Date:  1989-06       Impact factor: 9.410

9.  Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery.

Authors:  M G Mythen; A R Webb
Journal:  Arch Surg       Date:  1995-04

10.  Agreement of central venous saturation and mixed venous saturation in cardiac surgery patients.

Authors:  Michael Sander; Claudia D Spies; Achim Foer; Lisa Weymann; Jan Braun; Thomas Volk; Herko Grubitzsch; Christian von Heymann
Journal:  Intensive Care Med       Date:  2007-05-25       Impact factor: 17.440

View more
  5 in total

1.  Feasibility and influence of hTEE monitoring on postoperative management in cardiac surgery patients.

Authors:  S Treskatsch; F Balzer; F Knebel; M Habicher; J P Braun; M Kastrup; H Grubitzsch; K-D Wernecke; C Spies; M Sander
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-06       Impact factor: 2.357

Review 2.  [Volume replacement in intensive care medicine].

Authors:  B Nohé; A Ploppa; V Schmidt; K Unertl
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

Review 3.  [Hemodynamic monitoring in intensive care and emergency medicine : Integration of clinical signs and ultrasound findings].

Authors:  D Hempel; R Pfister; G Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-09       Impact factor: 0.840

Review 4.  [How should anesthesiologists perform ultrasound examinations? Diagnostic use of ultrasound in emergency and intensive care and medicine].

Authors:  T Maecken; H Zinke; M Zenz; T Grau
Journal:  Anaesthesist       Date:  2011-03       Impact factor: 1.041

Review 5.  [Perioperative fluid management in major abdominal surgery].

Authors:  M von der Forst; S Weiterer; M Dietrich; M Loos; C Lichtenstern; M A Weigand; B H Siegler
Journal:  Anaesthesist       Date:  2021-02       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.